Neurizon hopes to initiate its regimen of the HEALEY-ALS trial in Q4 2025. Image credit: MAXIMUM ART / Shutterstock.com The US Food and Drug Administration (FDA) has released its clinical hold on ...
Eric Dane opened up to Aaron Lazar about his ALS battle months before he went public with his health crisis. The “Grey's Anatomy” star revealed in April that he is battling ALS (amyotrophic lateral ...
Australian biotech Neurizon Therapeutics (ASX: NUZ) said the US regulator has lifted the clinical hold on its lead drug NUZ-001 (monepantel) for amyotrophic lateral sclerosis, clearing the way for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback